Association of Adipokines with Alzheimer’s Disease in a Chinese Cohort
Journal of Alzheimer’s Disease · 07.11.2023 · 96 (2) · 523-533
DOI: 10.3233/jad-220860 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Alzheimer’s Disease, online erschienen am 03.10.2023. Verfasst von Cheng-Chun Liu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology and Center for Clinical Neuroscience, Daping Hospital, Third Military Medical University, Chongqing, China. Hauptthemen laut MEDLINE: Adipokines, Alzheimer Disease. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 65 Literaturangaben.
Themen: Demenz
Abstract (Originalsprache)
Background
The correlation between plasma adipose factor levels and Alzheimer’s patients is not entirely clear.
Objective
We aimed to investigate associations between AD and plasma levels of three adipokines including plasma adiponectin, leptin, and resistin.
Methods
A single-center, cross-sectional study recruited AD patients ( n = 148) and cognitively normal (CN) controls ( n = 110). The multivariate logistic regression analysis was applied to determine associations of adiponectin, leptin, and resistin with the presence of AD. The receiver operating characteristic (ROC) analysis was employed to determine the diagnostic power of adiponectin, leptin and resistin for AD.
Results
After adjusted for the conventional risk factors, plasma levels of leptin (OR = 0.417, 95% CI: 0.272-0.638, p < 0.0001) and adiponectin (OR = 1.249, 95% CI: 1.151-1.354, p < 0.0001) were associated with the presence of AD. In total participants, the plasma adiponectin level was negatively correlated with MMSE scores ( p < 0.0001) and was positively with CDR scores ( p < 0.0001) and age ( p < 0.0001). The plasma level of leptin was negatively correlated with CDR scores ( p < 0.0001) and positively correlated with MMSE scores ( p < 0.0001). Both adiponectin ( p < 0. 0001) and leptin ( p < 0. 0001) featured higher AUC than the random chance.
Conclusions
Plasma adiponectin and leptin were associated with the presence, symptomatic severity, and diagnostic power of AD, suggesting a potential role of adipokines in the pathogenesis of AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology and Center for Clinical Neuroscience, Daping Hospital, Third Military Medical University, Chongqing, China.
- Chongqing Key Laboratory of Ageing and Brain Diseases, Chongqing, China.
- Department of Neurology, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.
Zitieren
APA
Liu, C. C., Wang, Q. H., Xin, J. Y., Liu, Y. H., Zeng, F., Chen, D. W., Li, H. Y., Yi, X., Zeng, G. H., Wang, Y. J., Xiang, Y., & Chen, Y. (2023). Association of Adipokines with Alzheimer’s Disease in a Chinese Cohort. Journal of Alzheimer’s Disease, 96(2), 523-533. https://doi.org/10.3233/jad-220860
Vancouver
Liu CC, Wang QH, Xin JY, Liu YH, Zeng F, Chen DW, et al. Association of Adipokines with Alzheimer’s Disease in a Chinese Cohort. Journal of Alzheimer’s Disease. 2023;96(2):523-533. doi:10.3233/jad-220860
BibTeX
@article{Liu2023,
author = {Liu, Cheng-Chun and Wang, Qing-Hua and Xin, Jia-Yan and Liu, Yu-Hao and Zeng, Fan and Chen, Dong-Wan and Li, Hui-Yun and Yi, Xu and Zeng, Gui-Hua and Wang, Yan-Jiang and Xiang, Yang and Chen, Yang},
title = {Association of Adipokines with Alzheimer’s Disease in a Chinese Cohort},
journal = {Journal of Alzheimer’s Disease},
year = {2023},
volume = {96},
number = {2},
pages = {523--533},
doi = {10.3233/jad-220860}
}
EUVIMED